What is BHRT and how do I know if I need it?

Short answer

• BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the ones your body makes (usually estradiol, progesterone, testosterone, sometimes DHEA).
• You might consider BHRT if you have moderate–severe symptoms of hormone deficiency (menopause or surgical menopause in people assigned female at birth, or low testosterone symptoms in people assigned male at birth) and lifestyle measures haven’t helped — but whether you “need” it is a medical decision made with a clinician after assessing symptoms, testing, and risks.

What BHRT means

• “Bioidentical” refers to the chemical structure of the hormone being the same as human hormones (for example, 17β-estradiol or micronized progesterone).
• BHRT can be delivered as FDA‑approved products (pills, patches, rings, gels) or as custom‑compounded preparations from compounding pharmacies. The FDA‑approved options have known dosing and regulatory oversight; compounded products are not FDA‑reviewed and vary in dose/quality.

Who commonly considers BHRT

• People with menopausal symptoms: hot flashes, night sweats, vaginal dryness/pain with sex, sleep problems, mood changes, low libido, or bone loss.
• People who had surgical removal of ovaries (sudden drop in hormones).
• People (usually men) with clinically low testosterone causing persistent low libido, fatigue, muscle loss, or anemia.
• Note: not everyone with mild symptoms needs hormones, and some symptoms have nonhormonal treatments.

How clinicians decide whether you need BHRT

1. Symptom review and medical history (including personal/family history of breast cancer, heart disease, stroke, blood clots).
2. Physical exam and baseline tests as appropriate — common labs: serum estradiol, FSH (in women around menopause), total and free testosterone, SHBG, and other routine labs (lipids, glucose). Bone density (DEXA) if bone loss is a concern. Labs are usually done through mainstream labs such as Quest Diagnostics or LabCorp.
3. Discuss risks and benefits in your situation. Menopausal estrogen therapy reduces hot flashes and protects bone but can increase risks (varies by age, dose, route, and personal risk factors). Progesterone is usually given to people with a uterus to reduce uterine cancer risk from unopposed estrogen.
4. If hormones are appropriate, choose an evidence‑based formulation and dose, start lowest effective dose, and plan follow‑up (symptom check, safety labs, periodic reassessment).

Testing notes

• Hormone levels fluctuate (especially in perimenopause), so tests aren’t always definitive. For menopause in middle age, clinicians often use symptoms and age plus selective labs rather than rely solely on a single hormone number.
• Saliva or urine hormone testing is sometimes used by compounding pharmacies, but these tests are not standardized and their clinical value is debated.

Benefits and risks — brief

• Benefits: effective relief of hot flashes/night sweats, improvement in sleep, mood, sexual function, and bone protection (estrogen).
• Risks: depend on hormone type, dose, route (oral vs transdermal), and individual risk factors. Possible increased risk of blood clots, stroke, and breast cancer in certain settings. Testosterone in women has limited high-quality data and requires careful dosing/surveillance.

Practical recommendations (brands and services)

• Prefer FDA‑approved, regulated products when appropriate because dose and quality are consistent:
  • Estradiol patches: Vivelle‑Dot, Climara (widely used for menopausal estrogen).
  • Oral estradiol: Estrace (estradiol).
  • Vaginal estrogen for local symptoms: Estring (ring), Vagifem (tablet) — good for vaginal dryness/urinary symptoms with lower systemic exposure.
  • Micronized progesterone (preferred bioidentical progesterone): Prometrium (oral).
  • Testosterone (for men with clinically low T): AndroGel, Testim (topical gels). Note: female testosterone therapy is less standardized and often off‑label; discuss carefully with your clinician.
• If considering compounded BHRT (creams, troches, pellets), be cautious: compounded products are not FDA‑approved. If you go this route, use a reputable, accredited compounding pharmacy (look for PCAB accreditation and strong quality reviews). Pellet therapy (brands like BioTE) is popular in some clinics but has more limited evidence and some safety considerations — review pros/cons with a specialist.
• Where to get care and testing: see a menopause specialist, endocrinologist, or a clinician with menopause certification (North American Menopause Society — NAMS — has resources). Large health systems with menopause clinics (Mayo Clinic, Cleveland Clinic) and reputable telehealth providers that focus on menopause (for example, Gennev or Elektra Health) can also be options. Use major labs (Quest, LabCorp) for testing.

Next steps

1. Track your symptoms (type, frequency, severity) and any other medical conditions/medications.
2. Make an appointment with your primary care clinician, gynecologist, or a menopause specialist. Ask about their experience with BHRT and whether they prefer FDA‑approved formulations versus compounding.
3. If you proceed, start with baseline testing and an individualized treatment plan with clear follow‑up.

If you want, tell me:

• Your sex assigned at birth, age, main symptoms, and any relevant medical history (breast cancer, blood clots, cardiovascular disease), and I can outline tests and a likely next step you could discuss with a clinician.